Jump to Main Content


Volker Diehl

Volker Diehl, MD

Volker Diehl, MD, is well known for his pioneering research on Hodgkin lymphoma. His scientific achievements include the discovery of the causative role of the Epstein-Barr virus in infectious mononucleosis and the study of its association with Hodgkin lymphoma. Dr. Diehl also cultured the first notoriously fragile Hodgkin cell lines and led the development of BEACOPP, a chemotherapy regimen for the treatment of Hodgkin lymphoma.

He has received much recognition for his work, including the German Johann Georg Zimmermann Prize for Cancer Research, and is chairman of the German Hodgkin Lymphoma Study Group, one of the largest Hodgkin studies in the world, which he founded in 1978. Dr. Diehl is also an honorary member of the Moscow Academy of Medicine, the European Society of Radio-Oncology, the Belgian Society of Radio-Oncology, the German Society of Radio-Oncology, the Hungarian Society of Hematology, and the German Society of Internal Medicine.

Wallace H. Coulter Award for Lifetime Achievement in Hematology

In 2010, Dr. Diehl received the Wallace H. Coulter Award for Lifetime Achievement in Hematology, the Society's highest honor. View the video below to learn more about the award and Dr. Diehl’s contributions to the field.